Hsiangyi Chiang - 29 Aug 2022 Form 3 Insider Report for Imago BioSciences, Inc.

Role: Senior Vice President Finance
Signature: /s/ Hugh Rienhoff, as Attorney-in-fact for Hsiangyi Chiang
Issuer symbol: N/A
Transactions as of: 29 Aug 2022
Net transactions value: $0
Form type: 3
Filing time: 02 Sep 2022, 17:38:43 UTC
Next filing: 14 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IMGO	Common Stock						5,000	29 Aug 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IMGO	Stock Option (Right to Buy)							29 Aug 2022	Common Stock	106,147	$4.20	Direct	F1
holding	IMGO	Stock Option (Right to Buy)							29 Aug 2022	Common Stock	23,500	$22.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option (original amount of 119,047) vests with respect to 25% of the shares subject thereto on February 5, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F2	One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 17, 2021 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Content

The option (original amount of 119,047) vests with respect to 25% of the shares subject thereto on February 5, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 17, 2021 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.